Literature DB >> 21400624

Identification of submicroscopic chromosomal aberrations in fetuses with increased nuchal translucency and apparently normal karyotype.

T Y Leung1, I Vogel, T K Lau, W Chong, J A Hyett, O B Petersen, K W Choy.   

Abstract

OBJECTIVE: Fetal nuchal translucency (NT) is assessed by ultrasonography as a screening tool for aneuploidy at 11 to 13 + 6 weeks' gestation. Fetuses with increased NT but apparently normal karyotype are still at higher risk of structural abnormality and a range of genetic syndromes, which may be related to major and submicroscopic chromosomal abnormalities. The aim of this study was to report the prevalence of submicroscopic chromosomal abnormalities in a cohort of apparently euploid fetuses that presented with increased NT.
METHODS: DNA was extracted from stored chorionic villus samples from fetuses found to have increased NT (> 3.5 mm) during first-trimester screening. These samples were examined by microarray-based comparative genomic hybridization (aCGH) using a 44K oligonucleotide array specifically constructed for prenatal screening. Variations in copy number (CNVs) were reported after excluding known non-pathogenic variants and after validation with multiplex ligation-dependent probe amplification (MLPA) or real-time quantitative polymerase chain reaction (qPCR). The prevalence of pathogenic CNVs is reported and the association with NT and other ultrasound findings described.
RESULTS: CNVs were reported in 6/48 (12.5%) cases by aCGH and the microdeletions or microduplications ranged from 1.1 to 7.9 Mb. Five of these were validated by MLPA/real-time qPCR and four (8.3%) were considered to be pathogenic and clinically significant. The incidence of pathogenic CNVs was 20.0% (2/10) among those cases with other sonographic anomalies and 5.3% (2/38) among those without.
CONCLUSION: aCGH allows detection of submicroscopic chromosomal abnormalities, the prevalence of which may be increased in fetuses with NT > 3.5 mm and an apparently normal karyotype.
Copyright © 2011 ISUOG. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21400624     DOI: 10.1002/uog.8988

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  25 in total

1.  Microarrays as a diagnostic tool in prenatal screening strategies: ethical reflection.

Authors:  Antina de Jong; Wybo J Dondorp; Merryn V E Macville; Christine E M de Die-Smulders; Jan M M van Lith; Guido M W R de Wert
Journal:  Hum Genet       Date:  2014-02       Impact factor: 4.132

Review 2.  Types of array findings detectable in cytogenetic diagnosis: a proposal for a generic classification.

Authors:  Malgorzata I Srebniak; Karin E M Diderich; Lutgarde C P Govaerts; Marieke Joosten; Sam Riedijk; Robert Jan H Galjaard; Diane Van Opstal
Journal:  Eur J Hum Genet       Date:  2013-11-06       Impact factor: 4.246

3.  Noninvasive prenatal diagnosis of common aneuploidies by semiconductor sequencing.

Authors:  Can Liao; Ai-hua Yin; Chun-fang Peng; Fang Fu; Jie-xia Yang; Ru Li; Yang-yi Chen; Dong-hong Luo; Yong-ling Zhang; Yan-mei Ou; Jian Li; Jing Wu; Ming-qin Mai; Rui Hou; Frances Wu; Hongrong Luo; Dong-zhi Li; Hai-liang Liu; Xiao-zhuang Zhang; Kang Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-05       Impact factor: 11.205

4.  Contribution of genomic copy-number variations in prenatal oral clefts: a multicenter cohort study.

Authors:  Ye Cao; Zhihua Li; Jill A Rosenfeld; Amber N Pursley; Ankita Patel; Jin Huang; Huilin Wang; Min Chen; Xiaofang Sun; Tak Yeung Leung; Sau Wai Cheung; Kwong Wai Choy
Journal:  Genet Med       Date:  2016-02-25       Impact factor: 8.822

5.  Analysis of quality of nuchal translucency measurements: its role in prenatal diagnosis.

Authors:  Carmen Comas Gabriel; M Echevarria; I Rodríguez; B Serra
Journal:  ScientificWorldJournal       Date:  2011-12-12

6.  Screening significantly hypermethylated genes in fetal tissues compared with maternal blood using a methylated-CpG island recovery assay-based microarray.

Authors:  Aihua Yin; Xiangzhong Zhang; Jing Wu; Li Du; Tianwen He; Xiaozhuang Zhang
Journal:  BMC Med Genomics       Date:  2012-06-18       Impact factor: 3.063

7.  Array comparative genomic hybridization in prenatal diagnosis of first trimester pregnancies at high risk for chromosomal anomalies.

Authors:  Isabel Filges; Anjeung Kang; Vanessa Klug; Friedel Wenzel; Karl Heinimann; Sevgi Tercanli; Peter Miny
Journal:  Mol Cytogenet       Date:  2012-09-17       Impact factor: 2.009

8.  Low-pass whole-genome sequencing in clinical cytogenetics: a validated approach.

Authors:  Zirui Dong; Jun Zhang; Ping Hu; Haixiao Chen; Jinjin Xu; Qi Tian; Lu Meng; Yanchou Ye; Jun Wang; Meiyan Zhang; Yun Li; Huilin Wang; Shanshan Yu; Fang Chen; Jiansheng Xie; Hui Jiang; Wei Wang; Kwong Wai Choy; Zhengfeng Xu
Journal:  Genet Med       Date:  2016-01-28       Impact factor: 8.822

9.  A rare de novo duplication of chromosome 21q22.12 → q22.3 with other concomitant deletion and duplication of small fragments in 21q associated with Down syndrome: Prenatal diagnosis, molecular cytogenetic characterization.

Authors:  Qingwei Qi; Xiya Zhou; Yulin Jiang; Na Hao; Jing Zhou; Liang Zhang
Journal:  Mol Cytogenet       Date:  2013-03-06       Impact factor: 2.009

10.  Noninvasive prenatal molecular karyotyping from maternal plasma.

Authors:  Stephanie C Y Yu; Peiyong Jiang; Kwong W Choy; Kwan Chee Allen Chan; Hye-Sung Won; Wing C Leung; Elizabeth T Lau; Mary H Y Tang; Tak Y Leung; Yuk Ming Dennis Lo; Rossa W K Chiu
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.